- Filed
- Mar 17, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · Mar 13, 2026 | 228.02M sh |
| Shares Diluted | Q3 2026 · Jan 31, 2026 | 195.5M sh |
| Shares Diluted | Q3 2026 · Jan 31, 2026 | 184.01M sh |
| Shares Diluted | Q3 2026 · Jan 31, 2025 | 147.54M sh |
| Shares Diluted | Q3 2026 · Jan 31, 2025 | 112.63M sh |
| Capex | Q3 2026 · Jan 31, 2026 | $1.75M |
| Capex | Q3 2026 · Jan 31, 2025 | $350K |
| Operating Cash Flow | Q3 2026 · Jan 31, 2026 | −$19.92M |
| Operating Cash Flow | Q3 2026 · Jan 31, 2025 | −$14.63M |
| Cash And Equivalents | Q3 2026 · Jan 31, 2026 | $7.06M |
| Cash And Equivalents | Q3 2026 · Apr 30, 2025 | $6.72M |
| Stockholders Equity | Q3 2026 · Jan 31, 2026 | $20.09M |
| Stockholders Equity | Q3 2026 · Oct 31, 2025 | $22.3M |
| Stockholders Equity | Q3 2026 · Apr 30, 2025 | $26.65M |
| Stockholders Equity | Q3 2026 · Jan 31, 2025 | $28.91M |
| Stockholders Equity | Q3 2026 · Oct 31, 2024 | $22.12M |
| Stockholders Equity | Q3 2026 · Apr 30, 2024 | $19.34M |
| Current Liabilities | Q3 2026 · Jan 31, 2026 | $19.7M |
| Current Liabilities | Q3 2026 · Apr 30, 2025 | $3.29M |
| Total Liabilities | Q3 2026 · Jan 31, 2026 | $21.05M |
| Total Liabilities | Q3 2026 · Apr 30, 2025 | $4.14M |
| Current Assets | Q3 2026 · Jan 31, 2026 | $21.11M |
| Current Assets | Q3 2026 · Apr 30, 2025 | $13.62M |
| Total Assets | Q3 2026 · Jan 31, 2026 | $41.14M |
| Total Assets | Q3 2026 · Apr 30, 2025 | $30.79M |
| Eps Diluted | Q3 2026 · Jan 31, 2026 | −$0.06 |
| Eps Diluted | Q3 2026 · Jan 31, 2026 | −$0.16 |
| Eps Diluted | Q3 2026 · Jan 31, 2025 | −$0.04 |
| Eps Diluted | Q3 2026 · Jan 31, 2025 | −$0.13 |
| Eps Basic | Q3 2026 · Jan 31, 2026 | −$0.06 |
| Eps Basic | Q3 2026 · Jan 31, 2026 | −$0.16 |
| Eps Basic | Q3 2026 · Jan 31, 2025 | −$0.04 |
| Eps Basic | Q3 2026 · Jan 31, 2025 | −$0.13 |
| Rd Expense | Q3 2026 · Jan 31, 2026 | $600K |
| Rd Expense | Q3 2026 · Jan 31, 2026 | $1.1M |
| Rd Expense restated | Q3 2026 · Jan 31, 2025 | $700K |
| Rd Expense restated | Q3 2026 · Jan 31, 2025 | $1.4M |
| Net Income | Q3 2026 · Jan 31, 2026 | −$11.37M |
| Net Income | Q3 2026 · Jan 31, 2026 | −$29.58M |
| Net Income | Q3 2026 · Jan 31, 2025 | −$6.72M |
| Net Income | Q3 2026 · Jan 31, 2025 | −$15.09M |
| Operating Income | Q3 2026 · Jan 31, 2026 | −$9.12M |
| Operating Income | Q3 2026 · Jan 31, 2026 | −$26.32M |
| Operating Income | Q3 2026 · Jan 31, 2025 | −$5.88M |
| Operating Income | Q3 2026 · Jan 31, 2025 | −$14.26M |
| Gross Profit | Q3 2026 · Jan 31, 2026 | −$755K |
| Gross Profit | Q3 2026 · Jan 31, 2026 | −$2.16M |
| Gross Profit | Q3 2026 · Jan 31, 2025 | $197K |
| Gross Profit | Q3 2026 · Jan 31, 2025 | $1.44M |
| Cost Of Revenue | Q3 2026 · Jan 31, 2026 | $1.27M |
| Cost Of Revenue | Q3 2026 · Jan 31, 2026 | $4.28M |
| Cost Of Revenue | Q3 2026 · Jan 31, 2025 | $628K |
| Cost Of Revenue | Q3 2026 · Jan 31, 2025 | $3.11M |